Longeveron® Results of Phase 2b Clinical Trial Demonstrating Stem Cell Therapy Improved Condition of Patients with ...

RIPK1 inhibition reduced inflammation and keratinocyte cell death in lichen planus and CLE models. Could this be a new ...

NSCLC remains the leading cause of cancer-related mortality worldwide, with EGFR mutations being a critical driver in approximately 10-15% of lung adenocarcinomas in Western populations, and up to 40% ...

Human epidermal growth factor receptor 2 (HER2)–positive (HER2+) breast cancers make up  15% to 20% of all breast tumors. In ...

Snakes shed because they grow out of their skin. But do you know you that you shed too? You constantly regenerate the outer layer of your skin, the epidermis. Imagine that you could shed your skin ...

Printing” skin grafts can improve patient quality of life after injury, but the technology faces barriers before it can become commercially available.

The agent, first approved in December for biweekly subcutaneous injection for EGFR-mutated NSCLC, showed similar efficacy and safety when administered monthly.

Plants don't just respond to light and water, they also run on an internal daily timekeeper known as the circadian clock. Researchers have now discovered that the plant circadian clock can regulate ...

FDA approves monthly dosing for J&J's Rybrevant Faspro with Lazcluze, offering faster, easier treatment for EGFR lung cancer.

Doctoral students work hand-in-hand with faculty researchers on advances such as a “band-aid” for the heart, non-invasive ...

Aging is often treated as a snapshot: a comparison between young and old, healthy and diseased. But according to the University of California, Riverside (UCR)’s bioengineering professor Joshua Morgan, ...